- ICH GCP
- Registro de ensaios clínicos dos EUA
- Ensaio Clínico NCT07565376
Effects of Exercise-Induced Muscle Damage on Neuromuscular Complexity (EIMD-NMC)
Effects of Exercise-Induced Muscle Damage Induced by Eccentric Exercise on Knee Extensor Torque, Oxygenation, and Electromyographic Properties: A Complexity-Based Approach
Visão geral do estudo
Status
Condições
Intervenção / Tratamento
Descrição detalhada
The present study was designed to investigate the impact of exercise-induced muscle damage , caused by eccentric exercise, on neuromuscular and physiological function of the knee extensor muscles. The research was based on the contemporary theoretical framework of the "loss of complexity," which proposes that physiological signal variability is not merely random noise, but rather an essential characteristic of healthy and adaptable biological systems. According to this approach, greater signal complexity reflects a more flexible and efficient neuromuscular control strategy, whereas reduced complexity indicates impaired adaptability and a more rigid functional state.
A total of eleven healthy young men (N = 11, age 27.8 ± 2.5 years) participated in the study. During the initial session, anthropometric characteristics were recorded and maximal voluntary isometric torque of the knee extensors was measured. The main testing procedure involved a sustained submaximal isometric contraction performed at 50% of maximal voluntary contraction for 60 seconds. During this task, torque output, muscle oxygenation, and electromyographic activity of the vastus lateralis were continuously was recorded in order to assess both mechanical and neuromuscular responses.
Following baseline testing, participants completed a muscle damage induction protocol consisting of five sets of fifteen maximal eccentric contractions performed at an angular velocity of 60°/s. This protocol was designed to induce structural and functional muscle impairment characteristic of exercise induced muscle damage. Forty-eight hours after the intervention, all measurements were repeated to determine the effects of muscle damage on the same variables. Data were processed and analyzed in MATLAB, with statistical significance set at p < .05.
The results are anticipated to confirm the successful induction of muscle damage.
The investigators wanted to show the effect of exercise induced muscle damage on torque complexity through changes in Sample Entropy, and changes on detrended fluctuation analysis exponent, which indicate that torque fluctuations will became more regular, predictable, and less complex.
A possible reduction in complexity it expected to be accompanied by a change in neuromuscular efficiency, meaning that a greater level of neural activation will be needed to produce the same relative mechanical output. A likely explanation is that damage to muscle fibers and sarcomeres would reduce the effectiveness of force transmission, forcing the nervous system to compensate through increased neural drive.
In parallel, it is expected that muscle oxygenation measurements will show increased deoxygenated hemoglobin, indicating higher oxygen extraction and a greater metabolic burden on the remaining functional muscle fibers. This finding would suggest that, after exercise induced muscle damage, fewer intact fibers may be available to share the workload, thereby increasing the relative demand placed on those still functioning effectively.
An additional important observation will be the possible changes in traditional linear variability indices, such as standard deviation and coefficient of variation. This will highlight the limitation of conventional linear measures in detecting subtle but functionally meaningful changes in neuromuscular regulation.
Tipo de estudo
Inscrição (Real)
Estágio
- Não aplicável
Contactos e Locais
Locais de estudo
-
-
Attica
-
Athens, Attica, Grécia, 17234
- School of Physical Education and Sport Science
-
-
Critérios de participação
Critérios de elegibilidade
Idades elegíveis para estudo
- Adulto
Aceita Voluntários Saudáveis
Descrição
Inclusion Criteria:
- No experience of resistance exercise with heavy loads the past 6 months
Exclusion Criteria:
- History of lower-limb injury
- Taking any medication
- Suffered from any pathological condition
- Participation in a systematic eccentric exercise program during the previous 6 months
Plano de estudo
Como o estudo é projetado?
Detalhes do projeto
- Finalidade Principal: Outro
- Alocação: Não randomizado
- Modelo Intervencional: Atribuição de grupo único
- Mascaramento: Nenhum (rótulo aberto)
Armas e Intervenções
Grupo de Participantes / Braço |
Intervenção / Tratamento |
|---|---|
|
Experimental: Eccentric exercise
All the parameters that was assessed 48 hours post isokinetic eccentric exercise
|
Isokinetic eccentric exercise consisted of 5 sets of 15 repetitions using the knee extensors.
The intensity of the exercise was the maximal voluntary and an interval of 1 minute was applied between sets.
|
O que o estudo está medindo?
Medidas de resultados primários
Medida de resultado |
Descrição da medida |
Prazo |
|---|---|---|
|
Isokinetic sub maximal exercise
Prazo: From enrollment to the end of the treatment at 48 hours
|
Isokinetic exercise of 60 seconds using the sub maximal intensity of 50% MVC.
The knee joint will be set at 90 degrees and the values will be in Nm.
|
From enrollment to the end of the treatment at 48 hours
|
|
Electromyography
Prazo: From enrollment to the end of treatment at 48 hours
|
Continuous recording of EMG during the 60 seconds isometric exercise.
Patches will be placed in vastus laterals and the recording will be at 100 Hz
|
From enrollment to the end of treatment at 48 hours
|
|
Muscle oxygenation
Prazo: rom enrollment to the end of treatment at 48 hours
|
Muscle oxygenation measured using near infrared spectroscopy (NIRS) of the knee extensors during the 60 seconds isometric exercise.
The main parameters that will be recored are the oxygenated haemoglobin, the deoxygenated haemoglobin, the total haemoglobin and the difference between oxygenated and deoxygenated haemoglobin.
|
rom enrollment to the end of treatment at 48 hours
|
Medidas de resultados secundários
Medida de resultado |
Descrição da medida |
Prazo |
|---|---|---|
|
Delayed onset muscle soreness
Prazo: From enrollment to the end of treatment at 48 hours
|
Assessment of subjective pain feeling assessed by palpation of knee extensors muscle belly.
The scale was set between 1 (no pain at all) to 10 (extreme pain).
|
From enrollment to the end of treatment at 48 hours
|
|
Range of Motion
Prazo: From enrollment to the end of treatment at 48 hours
|
The angles the knee joint may be flexed without the feeling of any pain.
The starting position was set at full extension.
|
From enrollment to the end of treatment at 48 hours
|
|
Peak torque output
Prazo: From enrollment to the end of treatment at 48 hours
|
Isometric peak torque output was assessed at 90 degrees knee joint angle (0 degrees was set at full extension).
The assessments was consisted of 3 set of 5 seconds each.
The higher performance was recorded for the data analysis
|
From enrollment to the end of treatment at 48 hours
|
Colaboradores e Investigadores
Patrocinador
Investigadores
- Investigador principal: Vassilis Paschalis, Dr., National and Kapodistrian Univesity of Athens
Datas de registro do estudo
Datas Principais do Estudo
Início do estudo (Real)
Conclusão Primária (Real)
Conclusão do estudo (Real)
Datas de inscrição no estudo
Enviado pela primeira vez
Enviado pela primeira vez que atendeu aos critérios de CQ
Primeira postagem (Real)
Atualizações de registro de estudo
Última Atualização Postada (Real)
Última atualização enviada que atendeu aos critérios de controle de qualidade
Última verificação
Mais Informações
Termos relacionados a este estudo
Palavras-chave
Outros números de identificação do estudo
- 1731/19-12-2024
Plano para dados de participantes individuais (IPD)
Planeja compartilhar dados de participantes individuais (IPD)?
Descrição do plano IPD
Informações sobre medicamentos e dispositivos, documentos de estudo
Estuda um medicamento regulamentado pela FDA dos EUA
Estuda um produto de dispositivo regulamentado pela FDA dos EUA
Essas informações foram obtidas diretamente do site clinicaltrials.gov sem nenhuma alteração. Se você tiver alguma solicitação para alterar, remover ou atualizar os detalhes do seu estudo, entre em contato com register@clinicaltrials.gov. Assim que uma alteração for implementada em clinicaltrials.gov, ela também será atualizada automaticamente em nosso site .